In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...